Technology | Ultrasound Transesophageal echo (TEE) | June 20, 2017

Stroke2prevent Receives FDA 510(k) Clearance for A-View

Medical device uses TEE to visualize the aortic arch during cardiac interventions

Stroke2prevent Receives FDA 510(k) Clearance for A-View
Stroke2prevent Receives FDA 510(k) Clearance for A-View

June 20, 2017 — Dutch medical device company Stroke2prevent BV recently announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for A-View, a medical device used in cardiac interventions. The A-View balloon catheter visualizes the aortic arch with transesophageal echocardiography (TEE).

A-View is intended to resolve the so-called blind spot of TEE, caused by interposition of the trachea. The device is used to provide imaging of the entire aortic arch and has demonstrated to detect atherosclerosis, diagnose aortic diseases and to monitor vascular flow. The additional information obtained by A-View supports surgeons to ensure the best patient outcomes.

A-View is currently marketed in Europe and will become available in the U.S. soon, pending arrangements for a proper distribution and clinical support channel.

For more information: www.stroke2prevent.com

Related Content

New echo technology and products at the 2018 ASE meeting.
Feature | ASE | June 22, 2018
More than 60 companies and organizations are displaying their latest products and services at the 2018 American Socie
GE Healthcare Vivid T8 cardiac ultrasound, highlights from the American Society of Echo ASE 2017
Feature | ASE | June 26, 2017
June 26, 2017 — Here is a list of some key clinical presentations and video interviews with cardiac ultrasound though
Videos | ASE | June 30, 2016
DAIC/ITN editor Dave Fornell shares some of the innovative new technologies on the show floor of the American Society
Overlay Init